Cardiac resynchronization improves coronary blood flow

Aydin Yildirim1, Ozer Soylu, Bahadir Dagdeviren

  • 1Cardiology Department, Siyami Ersek Thoracic and Cardiovascular Surgery Center, 21 Acibadem, Istanbul, Turkey. draydin@gmail.com

Insights

Cardiac resynchronization therapy (CRT) improves left ventricular (LV) function and coronary blood flow in patients with heart failure and left bundle branch block. Successful biventricular pacing enhances diastolic and systolic LV performance and increases distal left anterior descending artery velocities.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Medical Imaging

Background:

  • Left bundle branch block causes asynchronous ventricular activation, impairing left ventricular (LV) systolic and diastolic function.
  • Cardiac resynchronization therapy (CRT) aims to improve LV performance in heart failure patients with dyssynchrony.
  • The impact of CRT on myocardial blood flow remains incompletely understood.

Purpose of the Study:

  • To investigate the effect of CRT on coronary blood flow in patients with idiopathic dilated cardiomyopathy and left bundle branch block.
  • To assess changes in coronary flow velocities and their relationship with LV function during CRT.

Main Methods:

  • Twenty patients with idiopathic dilated cardiomyopathy received biventricular pacemakers for CRT.
  • Coronary blood flow velocities in the distal left anterior descending artery (LAD) were measured using Color Doppler echocardiography.
  • Measurements included peak diastolic and systolic velocities and velocity time integrals with CRT on and off.

Main Results:

  • Successful CRT significantly increased peak diastolic velocities and velocity time integral of the distal LAD.
  • CRT improved LV systolic and diastolic performance and reduced mitral regurgitation duration.
  • Diastolic filling time was also increased with successful biventricular pacing.

Conclusions:

  • Successful CRT with biventricular pacing enhances coronary blood flow velocities in the distal LAD.
  • CRT offers benefits beyond improved LV mechanics, including improved myocardial perfusion.
  • These findings support CRT as a therapy that positively impacts coronary hemodynamics in selected heart failure patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...